NASDAQ:GDTC

Cytomed Therapeutics Stock Forecast

etoro logo Buy GDTC
*Your capital is at risk
$0.97
-0.0001 (-0.0103%)
At Close: Jul 07, 2026
AI Analysis AI Analysis of GDTC AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add GDTC to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Cytomed Therapeutics Limited stock price ended at $0.97 on Tuesday, after losing 0.0103%
(Updated on Jul 07, 2026)

Sell candidate since Jul 02, 2026 Loss -0.52%

The Cytomed Therapeutics Limited stock price fell by -0.0103% on the last day (Tuesday, 7th Jul 2026) from $0.97 to $0.97. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 3.19% from a day low at $0.94 to a day high of $0.97. The price has fallen in 7 of the last 10 days and is down by -10.19% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -101 shares and in total, 1 thousand shares were bought and sold for approximately $1.16 thousand.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 9.40% during the next 3 months and, with a 90% probability hold a price between $0.88 and $1.51 at the end of this 3-month period.

GDTC Signals & Forecast

There are few to no technical positive signals at the moment. The Cytomed Therapeutics Limited stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.99 and $1.11. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, May 20, 2026, and so far it has fallen -26.52%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Cytomed Therapeutics Limited stock

Cytomed Therapeutics Limited finds support from accumulated volume at $0.95 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0300 between high and low, or 3.19%. For the last week the stock has had daily average volatility of 6.53%.

Cytomed Therapeutics Limited is oversold on RSI14 (24). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (GDTC) For The Upcoming Trading Day Of Wednesday 8th

For the upcoming trading day on Wednesday, 8th we expect Cytomed Therapeutics Limited to open at $0.96, and during the day (based on 14 day Average True Range), to move between $0.93 and $1.01, which gives a possible trading interval of +/-$0.0872 (+/-9.41%) up or down from last closing price. If Cytomed Therapeutics Limited takes out the full calculated possible swing range there will be an estimated 9.41% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.95 (1.98%) than the resistance at $1.07 (10.32%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Cytomed Therapeutics Limited stock A Buy?

The Cytomed Therapeutics Limited stock holds several negative signals and despite the positive trend, we believe Cytomed Therapeutics Limited will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -1.470 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 8, 2026 - $0.96 ( 1.02%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

GDTC Performance

Trading levels for GDTC

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.99 2.07%
R2 0.98 0.89%
R1 0.97 0.157%
Price 0.97
S1 0.95 -2.21%
S2 0.94 -2.94%
S3 0.93 -4.12%

Accumulated Volume Support & Resistance Levels

Level Price
R3 1.21 24.76%
R2 1.15 18.57%
R1 1.07 10.32%
Price 0.97
S1 0.95 -1.98%
S2 0.92 -5.14%
S3 0.780 -19.58%

FAQ

What is the symbol for Cytomed Therapeutics Limited Stock and on which exchange is it traded?
The symbol for Cytomed Therapeutics Limited is GDTC and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Cytomed Therapeutics Limited Stock?
The Cytomed Therapeutics Limited stock holds several negative signals and despite the positive trend, we believe Cytomed Therapeutics Limited will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Cytomed Therapeutics Limited Stock?
Cytomed Therapeutics Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cytomed Therapeutics Limited Stock.

What's the current price of Cytomed Therapeutics Limited Stock?
As of the end of day on the Jul 07, 2026, the price of an Cytomed Therapeutics Limited (GDTC) share was $0.97.

What is the 52-week high and low for Cytomed Therapeutics Limited Stock?
The 52-week high for Cytomed Therapeutics Limited Stock is $3.68 and the 52-week low is $0.680.

What is the market capitalization of Cytomed Therapeutics Limited Stock?
As of the Jul 07, 2026, the market capitalization of Cytomed Therapeutics Limited is 11.477M.

When is the next earnings date for Cytomed Therapeutics Limited?
The upcoming earnings date for Cytomed Therapeutics Limited is Nov 13, 2026.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
12.69% Jun 29
OSIS
$218.29
1.16% Jun 26
NMRK
$15.02
3.86% Jun 24
TTEK
$28.04
11.09% Jun 23
NESR
$25.07
10.21% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE